The Europe NPWT market size is predicted to be valued at USD 0.95 billion by 2028 from USD 0.73 billion in 2023, growing at a CAGR of 5.28% from 2023 to 2028.
The growing incidence of diabetes is the primary factor for the growth of the adverse pressure wound therapy market. According to the World Health Organization, diabetes affects nearly 52 million people in European countries. Factors such as changes in lifestyle, obesity, and increasing consumption of alcohol and smoking are primarily causing the increased glucose levels in the body and result in the diagnosis of diabetes. As a result, these diabetes patients are mostly suffering from diabetic foot ulcers, which take a long to recover from the wound due to changes in glucose levels in the body. An estimated 15% of diabetic people suffer from diabetic foot ulcers in the European region. Due to this, the adoption of NPWT is growing as it is one of the effective ways for fast recovery from wounds.
The growing number of c-section surgeries is predicted to boost Europe's negative pressure wound therapy market. Using negative pressure wound therapy for c-section women helps in the reduction of infection in the surgical site and helps in reducing complications. Negative pressure wound therapy also treats burns, accidents, chronic wounds, and others.
Furthermore, the growing number of negative pressure wound therapies advancements is estimated to promote the market’s growth rate in Europe. Prophylactic negative pressure wound therapy is developed for spinal fusion surgery and enables fast wound healing after the surgery. Key players are focused on cost-effective manufacturing devices with advanced technology which gives fast relief from pain. Along with this, the manufacturing of home care settings and single-use harmful pressure wound therapy devices to reduce the spread of the infection from one person to another helps push the market forward. Negative pressure wound therapy is also used for animal wounds promoting the market growth due to the increasing adoption of pets in many European households.
However, the growing costs associated with negative pressure wound therapy are majorly hampering European NPWT market growth. In addition, alternative treatments are another major factor restricting the European market growth. Furthermore, the lack of trained professionals, lack of reimbursement policies, and lack of awareness among the population in some of the European countries are anticipated to limit the growth rate of the European NPWT market.
This market research report on the European negative pressure wound therapy market has been segmented and sub-segmented into the following categories.
By Product Type:
The conventional NPWT devices segment is the most lucrative segment of all and is expected to hold a leading share of the European market during the forecast period.
By Wound Type:
The pressure ulcer segment led the European market in 2021 and is estimated to register a promising CAGR during the forecast period.
By End-User:
The hospital segment accounted for the largest European market share during the forecast period.
By Country:
The European region held a substantial share of the global market in 2022 and is predicted to showcase a notable CAGR due to the increasing adoption of negative pressure wound therapy treatment and growing healthcare expenditure. Owing to the increasing awareness programs regarding negative pressure wound therapy, the understanding levels of the European population regarding the available various NPWT procedures for various wounds that provide fast relief compared to the standard treatment. The devices remove the excess fluids from the wounds and reduce inflammation and pain, which helps for fast recovery.
During the forecast period, the UK market is anticipated to hold a major share of the European market owing to increasing approvals of advanced products. For instance, Smith & Nephew, a London-based company, launched its single-use negative pressure wound devices for the European people.
The German market is expected to showcase a promising CAGR in the coming years owing to the increasing adoption of negative pressure wound therapy, increasing number of training centers, and rising focus from the European governments to reduce errors during treatment. In addition, owing to increasing advancements in negative pressure wound therapies, the center training helps the healthcare professional to work more efficiently without any errors. Furthermore, the availability of NPWT at home has been growing considerably in Germany over the last few years. The adoption of NPWT among people aged and disabled is growing and boosting the German market growth.
KEY MARKET PLAYERS:
A few of the major market participants in the European negative pressure wound therapy market profiled in this report are Acelity, Smith & Nephew, Mölnlycke Health Care AB, Convatec Group, Cardinal Health, Paul Hartmann AG, Deroyal, Lohmann & Rauscher International, Cork Medical, Chongqing Sunshine Medical Industry, and Trading and Wuhan VSD Medical Science & Technology.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region